A Study to Compare Two Formulations of LY3819469 in Healthy Participants
NCT05932446
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
LY3819469
Sponsor
Eli Lilly and Company